Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2011
Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed
G J S Rustin
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
June 20, 2007
The role of CA 125 in epithelial ovarian carcinoma
H Mandeville, G J S Rustin
British Journal of Cancer
|
April 20, 2006
Lactate dehydrogenase is not a useful marker for relapse in patients on surveillance for stage I germ cell tumours
C Ackers, G J S Rustin
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2016
Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer?
G J S Rustin, M R Hall
The Oncologist
|
October 29, 2002
CA125 response: can it replace the traditional response criteria in ovarian cancer?
A E Guppy, G J S Rustin
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 7, 2005
Vascular disrupting agents: a new class of drug in cancer therapy
A M Gaya, G J S Rustin
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 27, 2007
Vascular damaging agents
D M Patterson, G J S Rustin
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 10, 2005
Epithelial ovarian cancer: a review of current management
A E Guppy, P D Nathan, G J S Rustin
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2004
Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population
H E Lambert, W M Gregory, A E Nelstrop, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 1, 2007
A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites
D M Patterson, N Murugaesu, L Holden, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2011
Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed
G J S Rustin
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|
June 20, 2007
The role of CA 125 in epithelial ovarian carcinoma
H Mandeville, G J S Rustin
British Journal of Cancer
|
April 20, 2006
Lactate dehydrogenase is not a useful marker for relapse in patients on surveillance for stage I germ cell tumours
C Ackers, G J S Rustin
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 1, 2016
Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer?
G J S Rustin, M R Hall
The Oncologist
|
October 29, 2002
CA125 response: can it replace the traditional response criteria in ovarian cancer?
A E Guppy, G J S Rustin
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
July 7, 2005
Vascular disrupting agents: a new class of drug in cancer therapy
A M Gaya, G J S Rustin
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
April 27, 2007
Vascular damaging agents
D M Patterson, G J S Rustin
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 10, 2005
Epithelial ovarian cancer: a review of current management
A E Guppy, P D Nathan, G J S Rustin
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
September 14, 2004
Long-term survival in 463 women treated with platinum analogs for advanced epithelial carcinoma of the ovary: life expectancy compared to women of an age-matched normal population
H E Lambert, W M Gregory, A E Nelstrop, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 1, 2007
A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites
D M Patterson, N Murugaesu, L Holden, et al.
Page
of 3